Ningbo MedicalSystem Biotechnology Co Ltd (300439.SZ) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · China · ISIN CNE100001Z25
Ningbo MedicalSystem Biotechnology Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.74 bn CNY | 1.54 bn CNY |
| Gross profit | 769.70 m CNY | 566.42 m CNY |
| Operating income | 267.53 m CNY | 61.40 m CNY |
| EBIT | 285.08 m CNY | 48.66 m CNY |
| Net income | 258.00 m CNY | 63.20 m CNY |
| Diluted EPS – continuing operations | 0.67 CNY | 0.16 CNY |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Ningbo MedicalSystem Biotechnology Co Ltd
Medicalsystem Biotechnology Co., Ltd. researches, develops, produces, and sells in vitro diagnostic products in China. It is also involved in the provision of third-party medical diagnostic services. The company offers chemiluminescence, biochemistry, integrated combination, TLA system, hematology, point-of-care testing (POCT), mass spectrometry, and blood lipid subfraction analysis. It also provides healthcare services. Medicalsystem Biotechnology Co., Ltd. was formerly known as Ningbo Medicalsystem Biotechnology Co., Ltd. and changed its name to Biotechnology Co., Ltd. in January 2017. The company was founded in 2003 and is based in Ningbo, China.
More stocks
- Bouvet ASA (BOUV.OL)
- Koppers Holdings Inc. (KOP)
- TLB Co. Ltd. (356860.KQ)
- ChengDa Pharmaceuticals Co. Ltd. (301201.SZ)
- Fanli Digital Technology Co Ltd (600228.SS)
- Ichitan Group Public Company Limited (ICHI.BK)
- Hangzhou Zhengqiang Corporation Limited (301119.SZ)
- Tungkong Inc (002117.SZ)
- Hyliion Holdings Corp. (HYLN)
- Waga Energy SA (WAGA.PA)
- MYRIAD GENETICS INC (MYGN)
- Shandong Teamgene Technology Co. Ltd. A (603151.SS)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.